Hrt Financial LP Karyopharm Therapeutics Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.87 - $1.58 $128,356 - $233,106	147,536 New	147,536 $128,000
Q2 2023 Aug 11, 2023	BUY	$1.79 - $4.59 $403,677 - $1.04 Million	225,518 New	225,518 $403,000
Q2 2022 Aug 12, 2022	BUY	$4.15 - $8.37 $203,491 - $410,414	49,034 New	49,034 $221,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $1.47 Million - $3.57 Million	-248,332 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $1.29 Million - $2.14 Million	248,332 New	248,332 $1.6 Million
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $157,501 - $282,863	-15,990 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $226,258 - $274,868	15,990 New	15,990 $247,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.